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The spike (S) glycoprotein of coronavirus is responsible for receptor binding and membrane fusion. A number of variants with deletions
and mutations in the S protein have been isolated from naturally and persistently infected animals and tissue cultures. Here, we report the
emergence and isolation of two temperature sensitive (ts) mutants and a revertant in the process of cold-adaptation of coronavirus infectious
bronchitis virus (IBV) to a monkey kidney cell line. The complete sequences of wild type (wt) virus, two ts mutants, and the revertant were
compared and variations linked to phenotypes were mapped. A single amino acid reversion (L294-to-Q) in the S protein is sufficient to
abrogate the ts phenotype. Interestingly, unlike wt virus, the revertant grows well at and below 32 jC, the permissive temperature, as it carries
other mutations in multiple genes that might be associated with the cold-adaptation phenotype. If the two ts mutants were allowed to enter
cells at 32 jC, the S protein was synthesized, core-glycosylated and at least partially modified at 40 jC. However, compared with wt virus
and the revertant, no infectious particles of these ts mutants were assembled and released from the ts mutant-infected cells at 40 jC. Evidence
presented demonstrated that the Q294-to-L294 mutation, located at a highly conserved domain of the S1 subunit, might hamper processing of
the S protein to a matured 180-kDa, endo-glycosidase H-resistant glycoprotein and the translocation of the protein to the cell surface.
Consequently, some essential functions of the S protein, including mediation of cell-to-cell fusion and its incorporation into virions, were
completely abolished.
D 2004 Elsevier Inc. All rights reserved.Keywords: Glycoprotein; Coronavirus; Virion
Introduction Goffart et al., 1997; Navas et al., 2001), and even whetherThe Coronaviridae family contains causative agents of a
wide spectrum of diseases affecting humans, mammals, and
birds. It is the etiologic agent of severe acute respiratory
syndrome (Drosten et al., 2003; Fouchier et al., 2003). The
molecular basis of host specificity and tissue or cell tropism
of coronavirus partially resides in the specific interaction
between the surface spike protein and cellular receptor(s).
This interaction would determine the outcome of infection:
whether it is acute or chronic and persistent (Rowe et al.,
1997a, 1997b), which organs or tissues are targeted, what
symptoms are shown (Ballesteros et al., 1997; Leparc-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Coronaviruses are a group of enveloped RNA viruses
with positive-sense, single-stranded genomes of 27 to 32 kb
that are packaged into helical structures by the nucleocapsid
protein (N). The viruses acquire their envelopes by budding
of the structural components into the intermediate compart-
ment (IC) between the endoplasmic reticulum (ER) and the
Golgi apparatus (Krijnse-Locker et al., 1994; Lai and
Cavanagh, 1998; Tooze et al., 1984). The membrane gly-
coprotein (M) and the envelope protein (E) mediate the
formation of the envelope, as they are involved in the
induction of virion assembly and incorporation of other
structural components into virus particles (Vennema et al.,
1996). The spike (S) glycoproteins incorporate into the
envelope (de Haan et al., 1999) in the form of homo-
oligomeric, 20 nm projections, giving the distinctive mor-
phology of the coronavirus virion. Some coronaviruses also
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ase (HE).
The largest structural S protein is a type I integral
membrane glycoprotein and spans the viral envelope once.
In some cases, the S protein is proteolytically cleaved into
the N-terminal S1 and the C-terminal S2 subunits of equal
size by a host proteinase (Sturman et al., 1985). The S1 and
S2 subunits are noncovalently associated to each other. A
hydrophobic transmembrane domain (TM) of S2 anchors on
the envelope with a short cytoplasmic-tail inside. One
Leucine-zipper (heptad repeats) domain overlaps with the
TM domain and another extends outside the envelope,
folding into a-helices and coiled-coil structures involved
in oligomerization (de Groot et al., 1987). It was found that
the TM domain and endodomain mediated the incorporation
of S into virions but the details of the S/M interaction
remain to be elucidated.
Although S protein is dispensable for the formation of
virus-like-particles (VLPs), its incorporation into virion is
critical to the assembly of infectious virus particles. The S
protein is cotranslationally N-glycosylated in the ER and
also forms stable complex with M in the pre-Golgi mem-
brane (Holmes et al., 1981; Opstelten et al., 1995; Sturman
et al., 1985). It was then transported to the Golgi apparatus
where its high mannose side chains are subsequently
trimmed and further modified. The matured S protein is
an Endo-glycosidase-H-resistant (Endo-H), 180-kDa form
(Luytjes et al., 1997). At the trans-Golgi, the matured
virions are encapsulated into vesicles of the constitutive
secretory pathway and released from infected cells. A
portion of S protein might be transported to the plasma
membrane and responsible for the cell-to-cell membrane
fusion, resulting in the formation of typical syncycia and
spread of virus infection to neighboring cells. The TM, Cys-
rich and Leucine-zipper domains of S2 and the disparate
region of S1 are associated with the membrane fusion
activity of the protein (Chang et al., 2000; Gallagher et
al., 1991; Krueger et al., 2001; Luo et al., 1999; Tsai et al.,
1999). Cleavage of the S protein enhances the membrane
fusion, though not necessarily required. The S protein
contains receptor-binding domains in the S1 subunit (Kubo
et al., 1994; Godet et al., 1994; Saeki et al., 1997; Suzuki
and Taguchi, 1996). Upon binding of the S protein to the
receptor(s), conformation changes induce the virus–cell
membrane fusion and subsequently unloading of the ribo-
nucleocapsid inside the cell. It has been demonstrated that
the cell-to-cell spread of MHV infection does not need the
presence of the receptor, but the S protein is required to
mediate the cell-to-cell fusion (Gallagher et al., 1992; Nash
and Buchmeier, 1996). For coronaviruses, however, the
detail of molecular mechanisms of membrane fusion, espe-
cially those linked to the S1 region, is yet to be fully
elucidated.
In this study, ts mutants were generated by growing
the Beaudette strain of IBV at progressively lower
temperatures from 35 to 28 jC in Vero cells. Two tsmutants were isolated from passages grown at 29 jC
(ts291602) and 28 jC (ts282902). A revertant was also
obtained by growing the ts mutant at the nonpermissive
temperature (40 jC). Sequence comparison revealed that
mutations in the S1 subunit were responsible for the ts
phenotype. Comparative studies of viral protein synthesis
and growth properties of the wt, ts mutant, and revertant
viruses demonstrated that the ts mutants were extremely
unstable at the nonpermissive temperature. If they were
allowed to enter cells by absorption for 1 h at the
permissive temperature (32 jC), the S protein would be
core-glycosylated and partially modified at the nonper-
missive temperature, but was unable to assemble into
virions. The membrane fusion activities of the ts mutants
were totally abolished in virus-infected cells and in cells
overexpressing the mutant S protein at the nonpermissive
temperature.Results
Cold-adaptation of wt virus, and isolation of two ts mutants
and a revertant
The Beaudette strain of IBV, grown in Vero cells at 37
jC, was plaque-purified and was initially adapted to grow
at 35 jC. After 4 passages, the virus was subsequently
adapted to grow at progressively lower temperatures by
culturing at 34 jC for 5 passages, 33 jC for 7 passages, 32
jC for 44 passages, 30 jC for 12 passages, 29 jC for 21
passages, and 28 jC for 29 passages. When the virus was
initially adapted to a lower temperature, no CPE was
observed within 72–96 h postinfection. Apparent CPE
appeared usually after 2 to 5 passages. The virus was
continuously passaged at the same temperature until CPE
became visible within 24–48 h postinfection, and then
shifted to a lower temperature.
Plaque assays of different passages were performed at
both 32 and 40 jC. It was found that viruses from early
passages grown at 32 jC could form plaques at both
temperatures at similar levels. But passages grown at 29
jC produced much fewer plaques at 40 jC than at 32 jC,
suggesting the emergence of ts mutants during cold-adap-
tation. These ts mutants dominated quickly at 28 jC.
Two ts mutants, designated ts291602 and ts282902, were
plaque-purified from passage 16 grown at 29 jC and
passage 29 grown at 28 jC, respectively. Plaque assays
showed that both ts291602 and ts282902 formed plaques
only at the permissive temperature, but not at all at the
nonpermissive temperature. By growing the ts mutant at 37
jC overnight and then at 40 jC for 2 days, a revertant, rev-
1, was obtained which produced plaques at both 32 and 40
jC at a similar level (Table 1). The titers of rev-1 were much
higher than that of the wild-type virus wt6501 (isolated from
passage 65 at 37 jC) at 32 jC, as it was derived from the
cold-adapted virus (Table 1).
Table 2
Summary of nucleotide (nt) and amino acid (aa) changes in the wild type,
mutant and revertant viruses
Nt (aa)
position
wt6501 ts291602 ts282902 rev-1
nt aa nt aa nt aa nt aa
195 kDa
5899 T Y C H C H C H
41 kDa
7472 C T T I T I T I
8865 A Q C H C H C H
34 kDa
10,253 G R A N A N A N
10,494 G K T N T N T N
Pol
13,032 C P T S T S T S
Hel
16286 T F C L C L C L
58 kDa
18195 T Y C H C H C H
S
21247/8(294) CA Q TT L TT L CA Q
22,492(709) G D A N G D G D
22,674(769) A I G M G M G M
23,659(1098) G V T L G V T L
23,841 C / T / T / T /
3a
23939/41(28) – I TAT I TAT I – I
3b
24074/5 +1A (FS) +1A (FS) +3A +K +1A (FS)
E
24,285 C L T F C L T F
24,420 C L A I A I A I
24,508 A D T V A D T V
Intergenic region between M and 5a
25,346 T / A / A / A /
25,413 TTAGA / – / – / – /
N
25902/3 / / +9 RTL +9 RTL +9 RTL
26,385 T / C / T / T /
3V-UTR
27,385 T / C / C / C /
27,461 T / C / T / C /
27,527 G / A / A / A /
Table 1
Titers of wild type, mutant and revertant viruses at 32 jC and 40 jC
(PFU/ml)
Titer
32 jC 40 jC
wt6501 8.5  103 5.5  106
ts291602 2.0  106 0
ts282902 3.2  106 0
rev-1 7.0  106 5.5  106
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To map the defects responsible for the ts phenotype
described above, the complete nucleotide sequences of
wt6501, ts291602, ts282902, and rev-1 were determined
using RT-PCR products and cDNA clones from each virus.
Comparison of the sequence of wt6501 with ts291602
revealed 22 point mutations, a 5-base-deletion, a 1-base-,
3-base- and a 9-base-insertion (Table 2). These alterations
caused 15 amino acid substitutions in eight mature viral
proteins, a single amino acid insertion in the 3a protein, a
truncated 3b (compared with early passages of wt virus)
caused by a single base insertion in the 3b of ts291602, and
a 3-amino acid insertion in the N protein. In ts282902,
similar point mutations, deletion and insertion were found
(Table 2). The most different feature of the two ts mutant is
the insertion in the 3b gene. In ts291602, a single A
insertion was found at a poly-A stretch at positions 24075
to 24080, causing frameshift of the 3b gene and resulting in
a C-terminally truncated 3b protein (Shen and Liu, 2003).
However, a three-A-insertion at the same poly-A stretch was
found in ts282902, which does not affect the open reading
frame of the 3b gene. Comparison of the sequence of rev-1
with the two ts mutants showed only one amino acid change
(Q294-to-L294) in the S protein and one amino acid deletion
in the nonstructural protein 3a (I28), which exists in both
ts291602 and ts 282902 but not in rev-1 and wt virus. The
genotype of the rev-1 at these two positions (Q294 and I28)
are therefore the same as that of wt6501, but different from
the two ts mutants. As both wt virus and the revertant could
form plaques at 32 and 40 jC, these two mutations might be
responsible for the ts phenotype. A Blast search of GenBank
clearly showed that the amino acid at position 294 of the S
protein was a conserved glutamine. The Leu294 residue in
the two ts mutants is located immediately downstream of a
hypervariable region and the upstream of a conserved region
of the S1 subunit. One additional mutation, D709–N709, was
found in ts291602 only, and an I769–M769 mutation in the
two ts mutants and rev-1.
Synthesis of the S protein
After mapping the potential determinants responsible for
the ts phenotype, we would like to explore the mechanisms
by which these mutations affect the propagation of the ts
mutants at the nonpermissive temperature. Synthesis of theS protein in cells infected with wt virus, ts mutants, and
revertant was analyzed. Two sets of experiments were
carried out. First, Vero cells were infected with wt6501,
ts291602, ts282902, and rev-1 at 32 and 40 jC, respectively,
and lysates were immunoprecipitated with anti-IBV anti-
bodies. It was obvious that synthesis of the ts mutant S
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lanes 3, 4, 5, and 6) under these conditions. In contrast,
expression of the S protein was observed in cells infected
with wt6501 and rev-1 at both temperatures (Fig. 1a, lanes
1, 2, 7, and 8), though the level of the proteins detected in
cells infected with wt6501 was much lower at 32 jC. This
was consistent with the lower titers of wt virus at 32 jC.
In the second set of experiments shown in Fig. 1b, cells
were absorbed with each virus at 32 jC for 1 h and one of
the duplicates was shifted to 40 jC. Under these conditions,
the two ts mutant S proteins were synthesized at both 32 and
40 jC (Fig. 1b, lanes 3, 4, 5, and 6), like those of the wt
virus and revertant (Fig. 1b, lanes 1, 2, 7 and 8). These
results indicated that the viral structural protein could be
synthesized at nonpermissive temperature if the mutants
were allowed to enter cells. The viral subgenomic RNA and
one of the processed proteins, the 3C-like proteinase, were
also detected in the same ways (data not shown), and the
results were consistent with those described above.
Fusogenic properties of the ts mutant S protein
Comparison of the nucleotide sequences and the S
protein synthesis of wt, ts mutants and revertant indicate
that the single amino acid mutation (Q294–L294) in the S
protein may be responsible for the temperature sensitivity of
the mutant virus. This possibility was studied by biochem-
ical and functional characterization of the S protein from the
revertant and a ts mutant.
The S gene of rev-1 and ts291602 was cloned under the
control of a T7 promoter to investigate whether membrane-
fusion activity was affected by the mutations in the S
protein. Cells were infected with recombinant vaccinia/T7a b
Fig. 1. Analysis of the expression of the S protein from wt (wt6501), ts mutants (
with each virus at 32 jC and 40 jC as indicated on the top for 1 h and were main
each virus at 32 jC for 1 h. One of the duplicates was maintained at 32 jC (lanes
Radiolabeled cell lysates were immunoprecipitated with anti-IBV antibodies. Th
autoradiography. Numbers on the left indicate molecular mass in kilodalton andvirus and were transfected with plasmids containing the S
gene from either ts291602 or rev-1. The expression of the S
proteins was analyzed by Western blotting using anti-IBV
antibodies. As shown in Fig. 2a, the S protein of both
revertant and ts mutant was expressed at 32 and 40 jC
(lanes 3, 4, 5, and 6), though the S protein of ts291602 was
expressed at a relatively lower level than the rev-1 at 40 jC
(compare lanes 4 and 6).
The fusion activity of the S protein derived from the
revertant and ts291602, respectively, was then examined. As
shown in Fig. 2b, membrane fusion was observed in cells
expressing the S gene of ts291602 at 32 jC (panel C) but
not at 40 jC (panel F), at 48 h posttransfection. In contrast,
membrane fusion was observed in cells expressing the S
gene of revertant at both 32 and 40 jC (panels B and E).
Interestingly, membrane fusion appeared at 72 h posttrans-
fection, after the cells expressing the S gene of ts291602
were shifted from 40 to 32 jC at 48 h posttransfection
(panel I).
Sensitivity of the ts mutant S protein to Endo-H digestion
The recombinant S genes of the ts mutant and revertant
were transfected into cells in 35 mm dishes at 32 jC and one
of the duplicates was shifted to 40 jC at 4 h posttransfection.
Radiolabeled proteins were immunoprecipitated and treated
with Endo-H at 37 jC. As shown in Fig. 3a, the ts mutant S
protein, synthesized at 40 jC, was sensitive to Endo-H
digestion, as no 180-kDa form was observed (lane 12). In
contrast, a portion of the ts mutant S protein, synthesized at
32 jC (lanes 10), was resistant to Endo-H digestion. The
revertant S protein, synthesized at both 32 and 40 jC, was
also resistant to Endo-H digestion (lanes 6 and 8). Thesets291602 and 282902) and revertant (rev-1) viruses. (a) Cells were infected
tained at the same temperatures. (b) Two dishes of cells were infected with
1, 3, 5, and 7) and the other one was shifted to 40 jC (lanes 2, 4, 6, and 8).
e proteins were separated on 12.5% polyacrylamide gels and detected by
the position of the S protein is indicated on the right.
Fig. 2. Membrane fusion activity of the S protein expressed from wt and ts291602. (a) Vero cells were transfected with plasmids without insert (lanes 1 and 2)
or with the S gene from the wt (lanes 3 and 4) and ts291602 (lanes 5 and 6), and were cultured at 32 jC (lanes 1, 3, and 5) or 40 jC (lanes 2, 4, and 6). The
expression of the S protein was examined in Western blot using anti-IBVantibodies, and h-tubulin was immunostained as loading controls. (b) The membrane-
fusion activity of the S protein from the wt (panels B, E, and H) and ts mutant (panels C, F, and I) at 32 jC (panels B and C) and 40 jC (panels C and F) 2 days
post-transfection was compared. Panels H and I show induction of membrane fusion on cells transfected with the wt and ts291602 by shifting cells shown in
panels E and F to 32 jC for 1 day. Panels A, D, and G show cells transfected with empty plasmids.
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jC was not a mature form of the glycoprotein.
In addition, a novel glycosylated form of the S protein,
migrating between the Endo-H treated 130-kDa and the
matured 180-kDa forms, was observed. It might represent
trimming of an initial, core-glycosylated form of the S
protein in the ER and the cis-Golgi. Interestingly, this band
was also observed in ts291602-infected cells (Fig. 3b, lane
2), when the incubation time at 32 jC was extended before
the culture was shifted to 40 jC. This band is much stronger
than the 180-kDa form (lane 2), giving direct evidence that
the mutations in the S protein of ts291602 dramatically
hampered the maturation process of the S glycoprotein.Compared with ts282902, the S protein of ts291602 con-
tains another amino acid substitution, D709–N709 (Table 1),
which is not present in the S protein of rev-1 and wt6501.
As this band was not observed in ts281602-infected cells
(data not shown), it is not clear at this point if this additional
mutation may also play a role in the maturation of the S
protein.
It was also noted that, at 40 jC for all viruses, the S1 and
S2 subunits were hardly detected in cell lysates but abun-
dant in the supernatants (Fig. 3b). At the nonpermissive
temperature, the S protein was not cleaved at all (lanes 2 and
6). These results may suggest that only the mature form of
the S glycoprotein could be cleaved into S1 and S2 and
Fig. 3. Maturation defects of the S protein from the ts mutant. (a) Endo-H treatment of the S protein from rev-1 and ts291602. The S protein derived from rev-1
(lanes 5, 6, 7, and 8) and ts291602 (lanes 9, 10, 11, and 12) were expressed in Vero cells at 32 jC (lanes 5, 6, 9, and 10) and 40 jC (lanes 7, 8, 11, and 12),
using a T7-vaccinia expression system. The radiolabeled proteins were immunoprecipitated with anti-IBV antibodies, the eluted proteins were Endo-H- (lanes
6, 8, 10, and 12) or mock-treated (lanes 5, 7, 9, and 11) and analyzed by SDS-PAGE. (b) Detection of the less matured S protein from ts291602 at 40 jC and the
defect in cleavage of the mutant S protein. Cells were infected with ts291602 and rev-1 for 5 h at 32 jC, one of the duplicates was maintained at 32 jC (lanes 1,
3, 5, and 7), and the other one was shifted to 40 jC (lanes 2, 4, 6, and 8). Cells were radiolabeled and viral proteins were immunoprecipitated with anti-IBV
antibodies and analyzed by SDS-PAGE. Lanes 1, 2, 3, and 4 refer to viral products detected from cell lysates and lanes 5, 6, 7, and 8 refer to viral proteins
detected from virus particles released to the cultured media.
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the ts mutants synthesized at the nonpermissive temperature
may represent a pre-mature form of the S glycoprotein.
Cell surface expression of the S protein in transfected Vero
cells
To detect whether the ts mutant S protein would be
transported to the plasma membrane at the nonpermissive
temperature, the S protein was transiently expressed in Vero
cells using the vaccinia virus-T7 expression system. The
transfected cells were treated with cycloheximide at 3.5
h posttransfection for 30 min to inhibit further proteinsynthesis. The cells were then incubated at 32 and 40 jC,
respectively. The subcellular localization of the S protein
was analyzed by indirect immunofluorescent staining at 4,
8, 16, and 24 h postinfection, respectively. The confocal
microscopy images of transfected cells are shown in Fig. 4.
Plasma membrane staining of the ts mutant S protein was
not observed at any time points posttransfection at 40 jC,
but was clearly seen at 32 jC at 16 and 24 h postinfection
(Fig. 4). The revertant S protein was expressed on the cell
surface at both temperatures at 16 and 24 h posttransfection.
These results may explain the lack of membrane fusion
activity of the ts mutant S protein in both infected and
transfected cells.
Fig. 4. Subcellular localization and translocation of the wt and ts mutant S
protein in Vero cells at the permissive- and nonpermissive temperatures. Vero
cells transiently expressing the wt and ts mutant S protein (as indicated on the
top) were treated with cycloheximide at 3.5 h posttransfection for 30 min and
were cultured at either 32 jC or 40 jC as indicated on the top. Cells were
incubated with anti-IBV antibodies and then with the FITC-conjugated
secondary antibodies at different time points as indicated on the left. The
fluorescence was viewed using a confocal scanning Zeiss microscope.
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type and ts mutant S protein was carried out by immu-
nofluorescent staining with anti-S protein antiserum and
the positive staining cells were sorted by flow cytometry.
As shown in Fig. 5, 5.5% of nonpermeabilizing (panel A)Fig. 5. Quantitative analysis of cell surface expression of the wt and ts mutant S prot
D, G, and I) and ts mutant (panels C, E, H, and J) were stained directly with 1:100 di
were also permeabilized with 0.1% saponin and stained with the same primary antise
swine anti-rabbit antibody (DAKO), fixed with 1% ice cold paraformaldehyde andand 0.7% of permeabilizing (panel F) cells expressing the
empty plasmid showed background staining. When the
cells were incubated at the permissive temperature, 3.8%
(9.2–5.5) of HeLa cells expressing the wt S protein
(panel B) and 4.1% (9.6–5.5) of cells expressing the ts
mutant S protein (panel C) displayed surface staining.
After permeabilizing with 0.1% saponin, 11.8% (12.5–
0.7) of cells expressing the wt S protein (panel G) and
10.9% (11.6–0.7) of cells expressing the ts mutant S
protein (panel H) showed positive staining. When the
cells were incubated at the nonpermissive temperature,
10.4% (15.9–5.5) of cells expressing the wt S protein
(panel D) and 2.3% (7.8–5.5) of cells expressing the ts
mutant S protein (panel E) exhibited surface staining.
After permeabilizing with 0.1% saponin, 9.3% (10–0.7)
of cells expressing the wt S protein (panel I) and 9.7%
(10.4–0.7) of cells expressing the ts mutant S protein
(panel J) showed positive staining. These results confirm
that the ts mutant S protein could not be efficiently
translocated to the cell surface at the nonpermissive
temperature.
Absence of the S protein in virions purified from
ts291602-infected cells at the nonpermissive temperature
To investigate whether the S protein of ts mutant was
assembled into virion or not, ts291602 and rev-1-infected
cells were radiolabeled and the virus particles were purified
through sucrose gradients twice. Immunoprecipitation of
the purified virions using anti-IBV antibodies showed that
the S protein of ts291602 was not detected at 40 jC (Fig. 6,
lane 2), but was observed at 32 jC (Fig. 6, lane 1). The S
protein was detected at both temperatures for rev-1 (Fig. 6,
lanes 3 and 4). These results render support that the spikeein. HeLa cells expressing the empty plasmid (panels A and F), wt (panels B,
luted rabbit anti-IBV S protein polyclonal antibodies (panels A–E). The cells
rum (panels F–J). Cells were then stained with 1:20 diluted FITC-conjugated
analyzed by flow cytometry. Percentages indicate positive staining cells.
Fig. 6. Analysis of the structural proteins on purified ts291602 and rev-1
virions. Immunoprecipitations were performed using virions, purified from
ts291602- (lanes 1 and 2) and rev-1-infected (lanes 3 and 4) Vero cells at 32
jC (lanes 1 and 3) and 40 jC (lanes 2 and 4). The viral proteins were
separated on 12.5% polyacrylamide gels and detected by autoradiography.
Numbers on the left indicate molecular masses in kilodalton and the
positions of the three structural proteins are indicated on the right.
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particles at 40 jC.Discussion
Coronavirus S protein is responsible for receptor binding
and membrane fusion. It also induces neutralizing antibodies
and bears determinants for virulence. A considerable diver-
sity in S protein among coronaviruses exists, which contrib-
utes to host specificity, cell and organ tropisms, and
pathogenesis. Characterization of mutants with point or
deletion mutations in the S protein has helped to establish
links between the variations and the functions or altered
antigenicity and virulence of viruses. Through sequence
analysis of wt virus, two ts mutants, a revertant and different
passages of a cold-adapted IBV, data presented in this study
not only mapped the defects of the ts mutants to the S gene,
but also revealed the molecular events occurred during
evolution of the IBV S gene. Compared with the parental
wt virus, mutations that are identical in the two ts mutants and
the revertant might be associated with the cold-adaptation
phenotype, while those identical only in the two mutants but
different from the revertant and wt virus were considered tobe linked to the ts phenotype. According to this criterion, the
Q294-to-L294 mutation in the S protein that exists in the two ts
mutants, and interestingly, occurred at a highly conserved
domain among IBV viruses immediately downstream a
variable domain in the S1 subunit may be responsible for
the ts phenotype. The mutants with this mutation accumulat-
ed and became dominant under selective pressures, in this
case, changes in the hosts and temperatures. The I769–M769
mutation emerged earlier than the Q294–L294 mutation,
which among variations in other gene products may be
associated with cold-adaptation, suggesting potential segre-
gation of mutations responsible for either cold-adaptation or
ts phenotypes. Further confirmation of the possibility that the
Q294-to-L294mutationmay cause the ts phenotypic changes is
currently being carried out by introducing the mutation to an
infectious IBV clones and isolation of a recombinant virus
containing this mutation only.
The S protein is co-translationally N-glycosylated in the
ER, oligomerized (Luytjes et al., 1997) if folded properly,
and associated with the M protein in pre-Golgi membrane
(Opstelten et al., 1995). One of the essential steps in N-
linked glycosylation is transfer of a preformed, 14-core-
unit-oligosaccharide to a specific Asn residue in the se-
quence Asn-X-Ser/Thr (where X is any residue except Pro,
Asp, or Glu). The oligosaccharide chain is donated by
dolichol-pyrophosphate-oligosaccharide to the protein
chain in the ER. It is trimmed down in the ER and cis-
Golgi, and different external sugars are then added to the
trimmed chain in the medial- and trans-Golgi. Glycopro-
teins with high mannose oligosaccharides in the ER and
cis-Golgi remain sensitive to Endo-H. They become Endo-
H resistant after being processed by the medial- and trans-
Golgi resident enzymes to glycoproteins with complex
oligosaccharides. The acquisition of Endo-H resistance is
therefore an indication that viral N-linked glycoproteins are
properly processed and transported to the Golgi apparatus
(Luo and Weiss, 1998; Luo et al., 1999; Luytjes et al.,
1997). Examination of the amino acid sequence of IBV S
protein showed that there are 13 and 9 potential glycosyl-
ation sites in the S1 and S2 subunits, respectively. The
calculated molecular weight of the S protein is 128 kDa. If
all 21 sites are used, the initially transferred oligosacchar-
ides account for 50 kDa. In cells overexpressing S protein,
core-glycosylation of the S protein in the ER resulted in a
180-kDa product as expected. Trimming of the S glyco-
protein in the ER and cis-Golgi led to a partially processed
155-kDa form, larger than the Endo-H-treated 130-kDa
form which only has one sugar residue left at each site.
Both the trimmed 155- and core-glycosylated 180-kDa
forms were sensitive to Endo-H digestion. At the permis-
sive temperature, further modification of the mutant S
protein in the medial- and trans-Golgi by addition of sugars
to the trimmed chains resulted in the maturation of S,
which co-migrates with the core-glycosylated 180-kDa
form but is resistant to Endo-H digestion. At the nonper-
missive temperature, however, no mature form of the
S. Shen et al. / Virology 326 (2004) 288–298296mutant S protein was produced. In virus-infected cells, the
Endo-H sensitive, 155-kDa form of ts291602 was abundant
at the nonpermissive temperature, clearly indicating that the
mutant S protein was trimmed in the ER and cis-Golgi but
was not transported to the trans-Golgi. Furthermore, the
mutant S protein was not cleaved into S1 and S2 at the
nonpermissive temperature, which usually occurs in the
trans-Golgi shortly before the release of virions from cells
(Frana et al., 1985). As only spikeless virions were pro-
duced, these results demonstrated that the core-glycosylated
or the trimmed forms of S were unable to incorporate into
virions. In addition, the mutant S protein fails to induce
cell–cell fusion at the nonpermissive temperature. As the
Q294-to-L294 mutation is not in the fusogenic domain of S,
it renders support to the conclusion that the mutation causes
the defect in its modification and intracellular transport,
instead of having direct impact on the fusion process.
Taken together, these studies clearly indicate that the
mutant S protein could not reach the site where the S
protein is incorporated into virions.
The reasons for the retention of the mutant S protein in
the ER and cis-Golgi are yet to be explored. Previous
studies show that the retention of monomeric S protein in
the ER is due to misfolding induced by disruption of
disulfide bonds (Opstelten et al., 1993), and also caused
by lack of oligomerization of Endo-H-sensitive S protein of
ts mutants though the locations were not determined
(Luytjes et al., 1997). It is not clear whether mutations in
IBV S protein have an effect on its folding or oligomeriza-
tion. Nevertheless, in both circumstances, the intracellular
transport, modification of the S protein and its incorporation
into virion would have been affected. Studies with some of
the other enveloped viruses demonstrated that molecular
chaperones (like calnexin and calreticulin) in the ER tran-
siently and specifically interact with partially trimmed,
monoglycosylated form of viral N-linked glycoproteins
(Tatu and Helenius, 1997). For instance, calnexin interacts
with the influenza hemagglutinin and vesicular stomatitis
virus G protein (Hebert et al., 1996; Hammond and Helen-
ius, 1994). These and other proteins could facilitate proper
folding and ensure quality control for viral glycoproteins.
Proteins that fail to fold and oligomerize are prevented from
transport and ultimately degraded. With the ts mutants, it is
possible to explore the interaction of the S protein with
molecular chaperones and folding enzymes. This approach
would provide new insights into the maturation and assem-
bly of the coronavirus S protein.
The ts mutant quickly lost its infectivity at the nonper-
missive temperature. This low thermostability indicated that
even if the mutant S protein was synthesized, fully modified
and assembled into virions at the permissive temperature,
the resulting particles were relatively unstable and lost
infectivity at the nonpermissive temperature. It suggests that
the Q294 residue in the conserved S1 domain of IBV may
also play an essential role in maintaining the thermal
stability of the spike in the virion, resembling the S287residue in the S1 region of an MHV ts mutant (Ricard et al.,
1995). In addition, if cells were incubated with the ts
mutants at the nonpermissive temperature, viral proteins
were hardly detected, indicating that at the nonpermissive
temperature, the ts mutant S protein may be unable to either
bind efficiently to the receptor or induce virus–cell mem-
brane fusion in contrast to the S protein of the revertant and
wt virus. This observation suggests that the mutation in the
S protein might induce conformation changes of the spikes
on virions at the nonpermissive temperature and hamper
either process.Materials and methods
Virus and cells
Vero cells were maintained in complete DMEM medi-
um (GIBCO BRL), supplemented with newborn calf
serum (10%), streptomycin (1000 Ag) and penicillin
(1000 units/ml).
The Beaudette stain of IBV was purchased from ATCC
and propagated in chicken embryonated eggs for three
passages. The virus was then adapted to grow and passage
on Vero cells for 65 times at 37 jC. In this study, the viruses
were further passaged on Vero cells at progressively lower
temperatures for 121 passages (at 35, 34, 33, 32, 30, 29, and
28 jC for 4, 5, 7, 44, 12, 21, and 29 passages). Virus stocks
were used for plaque assays, plaque-to-plaque purification
and viral RNA extraction as described previously (Shen et
al., 1994). The wild-type virus, wt6501, was plaque-purified
from passage 65 grown at 37 jC, while ts mutants, ts291602
and ts282902, were purified from passage 16 grown at 29
jC and passage 29 grown at 28 jC, respectively. The
revertant, rev-1, was plaque-purified from cells infected
with ts 291602 for 12 h at 37 jC and then shifted to 40
jC for 2 days.
Recombinant vaccinia/T7 (V/T3) virus was propagated
and was tittered on Vero cells. Virus stocks were kept at
80 jC until use.
Purification of viruses through sucrose gradient
Confluent monolayers of Vero cells were infected with
viruses at a multiplicity of infection (MOI) of 0.1. After 2-
h absorption, the viruses were radiolabeled by replacing
medium with methionine-free DMEM supplemented with
30 Aci/ml [35S]-methionine. After 16-h incubation at tem-
peratures appropriate for each virus, cells were harvested
and virus stock was prepared by freezing and thawing three
times. Cell debris was removed by centrifugation at 5000
rpm for 15 min (Beckmen, 25.50). The supernatant was
centrifuged through a 20% sucrose cushion and the resulting
pellet was resuspended in TNE buffer (50 mM Tris–HCl,
pH 7.4, 100 mM NaCl, 1 mM EDTA). The viruses were
further purified by centrifugation through a 20–55% su-
S. Shen et al. / Virology 326 (2004) 288–298 297crose gradient in TNE buffer at 45,000 rpm (Beckmen,
SW50) twice. Fractions containing the virus were pooled
together and used for protein analysis.
Analysis of viral structural proteins
Viral structural proteins were labeled with [35S]-methio-
nine, immunoprecipitated and separated on 12.5% poly-
acrylamide gels as described previously (Liu et al., 1998).
The anti-IBV serum was raised in rabbit against purified
IBV virions and was used in immunoprecipitation and
Western blot as previously described (Liu and Inglis, 1991).
Endo-glycosidase (Endo-H) treatment of the S proteins
A portion of cell lysates was immunoprecipitated with
anti-IBV serum. The pellets were washed three times with
standard RIPA buffer, dissolved in 20 Al of digestion buffer
(50 mM Tris, pH 6.8, 0.25% SDS) and incubated at 95 jC
for 5 min. Ten microliters of the supernatants were mixed
with 10 Al of digestion buffer with or without Endo-H (0.2
mU, Boehringer Mannheim) and incubated for 4 h at 37 jC.
Membrane fusion experiments
Confluent monolayers of Vero cells were infected with
recombinant vaccinia/T7 viruses at a MOI of 0.1. After 1-
h absorption, cells (2  107) were trypsinized, centrifuged at
250 g and resuspended in 2 ml of PBS. The cells (0.3 ml)
were mixed with 5 Ag plasmid and electroporated (Easyject,
EquiBio) at 600 V in a 0.4-cm cuvette (BioRad). The cells
were then plated in a 35-mm dish containing 3 ml of
DMEM with 2% of newborn calf serum and incubated at
temperatures indicated.
RT-PCR and sequencing
Viral RNA was extracted from the purified viruses using
the RNeasy Mini Kit (Qiagen) according to the manufac-
turer’s instructions. Reverse transcription and polymerase
chain reaction (RT-PCR) were performed using the Expand
Reverse Transcription and High Fidelity PCR Kits (Boeh-
ringer Mannheim). Annealing and extension times of PCR
were optimized for amplification of PCR products with
different sizes using different primers. More than 100
specific primers were used for amplification, sequencing
and cloning. Automated sequencing was carried out using
PCR products or cDNA clones and specific primers as
previously described (Shen et al., 1999). Sequence analysis
was carried out using the GCG and Blast suite of programs
as described previously (Shen and Liu, 2000).
Flow cytometry
HeLa cells were infected with vaccinia/T7 virus, trans-
fected with constructs encoding wt and ts mutant S proteinusing QIAGEN effectene transfection reagent, and incubat-
ed at the permissive and nonpermissive temperatures, re-
spectively, for 18 h. Cells were harvested, washed once with
PBS, resuspended in blocking buffer (20% FBS and 1%
BSA in PBS), incubated on ice for 30 min. A half of the
cells were permeabilized with 0.1% saponin in FACS
washing buffer (2.5% FBS and 0.05% sodium azide in
PBS) incubated for 10 min at room temperature, and stained
with 1:100 diluted primary antiserum, the rabbit anti-IBV S
protein. The other half was stained directly with the same
primary antibody. Cells were then washed two times with
the FACS washing buffer, stained with 1:20 diluted FITC
conjugated swine anti-rabbit antibody (DAKO). After wash-
ing two times with the FACS washing buffer, cells were
then fixed with 1% ice cold paraformaldehyde and analyzed
by flow cytometry.Acknowledgment
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